This Blog Is Powered By Life Technology™. Visit Life Technology™ At www.lifetechnology.com Subscribe To This Blog Via Feedburner / Atom 1.0 / RSS 2.0.
News
Life Technology™ Medical News Subscribe Via Feedburner Subscribe Via Google Subscribe Via RSS
Life Technology™ Science News Subscribe Via Feedburner Subscribe Via Google Subscribe Via RSS
Life Technology™ Technology News Subscribe Via Feedburner Subscribe Via Google Subscribe Via RSS
ews&detail=-1&showtitle=false&type=js">
Wednesday, July 13, 2022
WHO advises against use of two drugs for non-severe COVID-19
The antidepressant drug fluvoxamine and the gout drug colchicine are not recommended for patients with mild or moderate COVID-19 because there is currently insufficient evidence that they improve important outcomes for patients, and both drugs carry potential harms, says a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.